AA
ALK-Abelló Stock: price and insider trades · Denmark
ALK-Abelló: what insiders have been doing
Only a handful of insider records exist for ALK-Abelló, too few to describe a trend. Every figure here comes from the filings published by Finanstilsynet DK and describes the past, not future prices; it is not investment advice.
Insider Decl.
n/a
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Analyst consensus: bullish or bearish?
Analysts rate ALK-Abelló Strong Buy (bullish), based on 4 analysts. Average price target: DKK 298.75.
Fundamental score
Ranked 7,740 of 26,897 companies
62.2
score / 100
Value38
Quality86
FCF yld2.9%
Earn yld2.4%
EV/EBITDA25.6x
ROE21%
Gross mgn67%
Net mgn19%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
DKK 228.40
Analyst consensus
4 analystsStrong buy
DKK 290.00Target DKK 298.75(+31%)DKK 305.00
Income statement
RevenueDKK 6.3B
Gross profitDKK 4.2B67% margin
EBITDADKK 2B32% margin
Net incomeDKK 1.2B19.5% margin
Valuation
PER (trailing)39.4x
PER (forward)30.5x
P/Book7.7x
Beta0.72
Balance sheet & cash
Market capDKK 50.6B
Total debtDKK 418M
Free Cash FlowDKK 1.5B
Debt / Equity6%
Profitability & ownership
ROE20.9%
ROA12.6%
% institutions64.2%
Declarations0 total
No declarations found
0 of 0 declarations
About ALK-Abelló
ALK-Abelló is a company focused on developing treatments for allergies, particularly through immunotherapy. It is listed on the XCSE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
